Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

The scope of this focused update is limited to addressing recommendations on duration of
dual antiplatelet therapy (DAPT)(aspirin plus a P2Y12 inhibitor) in patients with coronary …

Antiplatelet therapy is key to reducing local thrombotic complications and systemic
ischaemic events among patients undergoing percutaneous coronary interventions (PCI) …

Background Dual antiplatelet therapy is recommended after coronary stenting to prevent
thrombotic complications, yet the benefits and risks of treatment beyond 1 year are …

Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention with drug-eluting stents remains uncertain. We compared short-term (< …

Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Background If percutaneous coronary intervention (PCI) is required in patients taking oral
anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Drug-Eluting Coronary-Artery Stents | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Background: The optimal duration of dual antiplatelet therapy (DAPT) following second-
generation drug-eluting stent (DES) implantation is still debated. Objectives: The aim of this …